Onderneming Natco Pharma Ltd. NSE India S.E.
Aandelen
INE987B01018
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- INR | - |
28/05 | INDIA STOCKS - Metaal- en farmaceutische aandelen stuwen Indiase benchmarks omhoog | RE |
28/05 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
Vakgebied
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
98,5
%
| 19 399 | 99,7 % | 26 662 | 98,5 % | +37,44% |
Agro Chemicals
1,5
%
| 49 | 0,3 % | 409 | 1,5 % | +734,69% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
59,3
%
| 9 782 | 50,3 % | 16 060 | 59,3 % | +64,18% |
Rest of the World
22,2
%
| 3 576 | 18,4 % | 5 997 | 22,2 % | +67,70% |
India
18,5
%
| 6 090 | 31,3 % | 5 014 | 18,5 % | -17,67% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 47 | 03-07-00 | |
Founder | 78 | 19-09-81 | |
Director of Finance/CFO | - | - | |
Chief Operating Officer | - | - | |
Compliance Officer | - | 01-04-22 | |
M. Pulla Reddy
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-04-94 |
Chief Tech/Sci/R&D Officer | 71 | 11-02-93 | |
Director/Board Member | - | - | |
Director/Board Member | 66 | 12-11-14 | |
Sadasiva N. Rao
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 78 | 19-09-81 | |
Chief Executive Officer | 47 | 03-07-00 | |
Director/Board Member | 70 | 18-04-14 | |
Leela Digumarti
BRD | Director/Board Member | - | 22-09-14 |
M. U. R Naidu
BRD | Director/Board Member | 74 | 11-02-15 |
Chief Tech/Sci/R&D Officer | 71 | 11-02-93 | |
Director/Board Member | 66 | 12-11-14 | |
Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 179 000 000 | 83 757 134 ( 46,79 %) | 0 | 46,79 % |
Bedrijfsgegevens
NATCO Pharma Ltd.
NATCO House Road No. 2
500034, Hyderabad
+91 40 2354 7532
http://www.natcopharma.co.inBedrijven van de groep
Naam | Categorie en sector |
---|---|
Natco Pharma (Canada), Inc.
|
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+45,82% | 754 mld. | |
+40,95% | 630 mld. | |
-6,16% | 352 mld. | |
+19,86% | 331 mld. | |
+9,32% | 298 mld. | |
+18,45% | 250 mld. | |
+11,88% | 217 mld. | |
-0,78% | 216 mld. | |
+5,90% | 164 mld. |
- Beurs
- Aandelen
- Koers NATCOPHARM
- Koers
- Onderneming Natco Pharma Ltd.